| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $219.6M | -26.7% |
| Cost of Revenue | $120.3M | -27.1% |
| Gross Profit | $99.4M | -26.1% |
| R&D Expense | $205.4M | -7.7% |
| SG&A Expense | $129.8M | +11.9% |
| Operating Income | -$681.5M | -110.3% |
| Pre-tax Income | -$666.6M | -112.0% |
| Income Tax | $73K | +102.6% |
| Net Income | -$666.7M | -113.9% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $216.5M | -44.0% |
| Accounts Receivable | $3.3M | +75.2% |
| Inventory | $12.5M | +21.6% |
| Current Assets | $255.3M | -39.9% |
| Total Assets | $395.2M | -58.1% |
| Current Liabilities | $127.3M | -14.8% |
| Total Liabilities | $206.6M | -9.6% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$164.3M | +0.6% |
| Capital Expenditures | $1.1M | -72.1% |
| Investing Cash Flow | -$9.6M | +14.9% |
| Financing Cash Flow | $3.6M | -63.3% |
| Free Cash Flow | -$165.4M | +2.4% |
| Stockholders' Equity |
| $188.5M |
| -73.6% |